Monterotondo, Italy

Gianluca Rinaldi

This inventor holds 13 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 12 EPO patents. Top assignees: Fresenius Kabi Deutschland Gmbh, Ares Trading S.a., Merck Patent Gmbh. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gianluca Rinaldi. Retrieved from https://idiyas.com/inventor/gianluca-rinaldi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 42(Granted Patents)


Location History:

  • Monterotondo, RO (2019)
  • Monterotondo, IT (2014 - 2023)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gianluca Rinaldi

Introduction

Gianluca Rinaldi is a prominent inventor based in Monterotondo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid compositions for drug delivery. With a total of 13 patents to his name, Rinaldi's work is paving the way for advancements in medication stability and accessibility.

Latest Patents

One of Rinaldi's latest patents focuses on a novel liquid pharmaceutical composition of adalimumab. This composition includes adalimumab or a biosimilar, a histidine buffering agent, and a sugar stabilizer such as trehalose. The combination of these components results in formulations that exhibit stability comparable to or better than existing options, while using fewer ingredients. This innovation aims to make adalimumab treatments more widely available at a lower cost and prolong the viability of pre-loaded delivery devices, such as pre-filled syringes, thereby reducing unnecessary waste of the drug.

Career Highlights

Throughout his career, Gianluca Rinaldi has worked with notable companies in the pharmaceutical industry, including Fresenius Kabi Deutschland GmbH and Ares Trading S.A. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Rinaldi has collaborated with several professionals in his field, including Alessandra Del Rio and Silvia Fratarcangeli. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Gianluca Rinaldi's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations and accessibility. His work continues to influence the industry positively, making significant strides in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…